Literature DB >> 21595601

The basophil activation test in the diagnosis of immediate drug hypersensitivity.

Julie Leysen1, Vito Sabato, Marjoke M Verweij, Kathleen J De Knop, Chris H Bridts, Luc S De Clerck, Didier G Ebo.   

Abstract

Hypersensitivity reactions to drugs account for 15% of all adverse drug reactions and represent an important health problem with significant morbidity and mortality. This article describes the current applications and perspectives of the basophil activation test by flow cytometry in the diagnosis of immediate-type drug allergy, with particular focus on its diagnostic performance in allergy to neuromuscular blocking agents, antibiotics and NSAIDs and on future applications.

Entities:  

Mesh：

Year:  2011        PMID： 21595601     DOI： 10.1586/eci.11.14

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


  12 in total

Review 1.  Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.

Authors:  Jason Trubiano; Elizabeth Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

Review 2.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

3.  Testing for drug hypersensitivity syndromes.

Authors:  Craig M Rive; Jack Bourke; Elizabeth J Phillips
Journal:  Clin Biochem Rev       Date:  2013-02

4.  Required cefazolin concentration to maximize diagnostic accuracy of the basophil activation test for cefazolin-induced anaphylaxis.

Authors:  Tatsuo Horiuchi; Tomonori Takazawa; Masaki Orihara; Shinya Sakamoto; Akihiko Yokohama; Junko Takahashi; Akihiro Tomioka; Nagahide Yoshida; Kazuaki Hagiwara; Shigeru Saito
Journal:  J Anesth       Date:  2018-09-17       Impact factor: 2.078

5.  Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins.

Authors:  Cosby A Stone; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-19

6.  Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Authors:  Mario Sánchez-Borges; Bernard Thong; Miguel Blanca; Luis Felipe Chiaverini Ensina; Sandra González-Díaz; Paul A Greenberger; Edgardo Jares; Young-Koo Jee; Luciana Kase-Tanno; David Khan; Jung-Won Park; Werner Pichler; Antonino Romano; Maria José Torres Jaén
Journal:  World Allergy Organ J       Date:  2013-10-31       Impact factor: 4.084

Review 7.  Diagnosis and management of immediate hypersensitivity reactions to cephalosporins.

Authors:  Min-Hye Kim; Jong-Myung Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-10-15       Impact factor: 5.764

8.  The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced Anaphylaxis.

Authors:  Suk Yeon Kim; Joo Hee Kim; Young Sook Jang; Jeong Hee Choi; Sunghoon Park; Yong Il Hwang; Seung Hun Jang; Ki Suck Jung
Journal:  Allergy Asthma Immunol Res       Date:  2016-11       Impact factor: 5.764

Review 9.  Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity.

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2013-10-31

10.  Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole.

Authors:  Adriana Ariza; Elena García-Martín; María Salas; María I Montañez; Cristobalina Mayorga; Natalia Blanca-Lopez; Inmaculada Andreu; James Perkins; Miguel Blanca; José A G Agúndez; María J Torres
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.